Shi H, Li Z, Zhu M
Curr Med Chem. 2024; 32(3):595-607.
PMID: 38698750
DOI: 10.2174/0109298673296618240424095548.
Pan Y, Shao S, Sun H, Zhu H, Fang H
Front Oncol. 2022; 12:985089.
PMID: 36091129
PMC: 9449313.
DOI: 10.3389/fonc.2022.985089.
Xia T, Li K, Niu N, Shao Y, Ding D, Thomas D
J Hematol Oncol. 2022; 15(1):37.
PMID: 35346322
PMC: 8962046.
DOI: 10.1186/s13045-022-01253-z.
Elsalem L, Jumah A, Alfaqih M, Aloudat O
Clin Exp Gastroenterol. 2020; 13:151-185.
PMID: 32440192
PMC: 7211962.
DOI: 10.2147/CEG.S243337.
Sim J, Kim Y, Kim H, Bang S, Jee S, Park S
In Vivo. 2019; 34(1):125-132.
PMID: 31882471
PMC: 6984102.
DOI: 10.21873/invivo.11753.
Mixed adenoneuroendocrine carcinoma of the extrahepatic bile duct: a case report.
Zhang H, Kou K, Qi J, Xie E, Wang M, Li Y
J Int Med Res. 2019; 47(7):3421-3426.
PMID: 31154920
PMC: 6683900.
DOI: 10.1177/0300060519850391.
Development and multicentre validation of a prognostic model to predict resectability of pancreatic head malignancy.
Gerken K, Roberts K, Reichert B, Sutcliffe R, Marcon F, Kamarajah S
BJS Open. 2018; 2(5):319-327.
PMID: 30263983
PMC: 6156170.
DOI: 10.1002/bjs5.79.
The diagnostic/prognostic potential and molecular functions of long non-coding RNAs in the exosomes derived from the bile of human cholangiocarcinoma.
Ge X, Wang Y, Nie J, Li Q, Tang L, Deng X
Oncotarget. 2017; 8(41):69995-70005.
PMID: 29050258
PMC: 5642533.
DOI: 10.18632/oncotarget.19547.
Successful immune checkpoint blockade in a patient with advanced stage microsatellite-unstable biliary tract cancer.
Czink E, Kloor M, Goeppert B, Frohling S, Uhrig S, Weber T
Cold Spring Harb Mol Case Stud. 2017; 3(5).
PMID: 28619747
PMC: 5593153.
DOI: 10.1101/mcs.a001974.
Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results.
Jia Z, Paz-Fumagalli R, Frey G, Sella D, McKinney J, Wang W
J Cancer Res Clin Oncol. 2016; 143(3):481-489.
PMID: 27826686
DOI: 10.1007/s00432-016-2291-4.
Genomics of gallbladder cancer: the case for biomarker-driven clinical trial design.
Sicklick J, Fanta P, Shimabukuro K, Kurzrock R
Cancer Metastasis Rev. 2016; 35(2):263-75.
PMID: 26857926
PMC: 4912391.
DOI: 10.1007/s10555-016-9602-8.
Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: a case report and review of the literature.
Zheng S, Yip V, Pedica F, Prachalias A, Quaglia A
Diagn Pathol. 2015; 10:204.
PMID: 26589730
PMC: 4654861.
DOI: 10.1186/s13000-015-0439-1.
Safety and feasibility of endoscopic biliary radiofrequency ablation treatment of extrahepatic cholangiocarcinoma.
Laquiere A, Boustiere C, Leblanc S, Penaranda G, Desilets E, Prat F
Surg Endosc. 2015; 30(3):1242-8.
PMID: 26162420
DOI: 10.1007/s00464-015-4322-7.
Role of laparoscopic ultrasound during diagnostic laparoscopy for proximal biliary cancers: a single series of 100 patients.
Russolillo N, DEletto M, Langella S, Perotti S, Lo Tesoriere R, Forchino F
Surg Endosc. 2015; 30(3):1212-8.
PMID: 26139492
DOI: 10.1007/s00464-015-4333-4.
Imaging of malignancies of the biliary tract- an update.
Hennedige T, Neo W, Venkatesh S
Cancer Imaging. 2015; 14:14.
PMID: 25608662
PMC: 4331820.
DOI: 10.1186/1470-7330-14-14.
Raf kinase inhibitor protein inhibits cholangiocarcinoma cell metastasis by downregulating matrix metalloproteinase 9 and upregulating tissue inhibitor of metalloproteinase 4 expression.
Ma J, Shi J, Zhao D, Cheng L, Wang W, Li F
Oncol Lett. 2014; 9(1):15-24.
PMID: 25435928
PMC: 4246646.
DOI: 10.3892/ol.2014.2637.
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups.
Simbolo M, Fassan M, Ruzzenente A, Mafficini A, Wood L, Corbo V
Oncotarget. 2014; 5(9):2839-52.
PMID: 24867389
PMC: 4058049.
DOI: 10.18632/oncotarget.1943.
MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers.
Macha M, Seshacharyulu P, Krishn S, Pai P, Rachagani S, Jain M
Curr Pharm Des. 2014; 20(33):5287-97.
PMID: 24479799
PMC: 4113605.
DOI: 10.2174/1381612820666140128213117.
Transarterial therapies for the treatment of intrahepatic cholangiocarcinoma.
Zechlinski J, Rilling W
Semin Intervent Radiol. 2014; 30(1):21-7.
PMID: 24436514
PMC: 3700793.
DOI: 10.1055/s-0033-1333650.
Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis.
Ma W, Lai H, Yeh S, Cai X, Chang C
Endocr Relat Cancer. 2014; 21(3):R165-82.
PMID: 24424503
PMC: 4165608.
DOI: 10.1530/ERC-13-0283.
